grid-line

Alto Neuroscience

Biotechnology company specializing in precision medicine for psychiatric drug development. The company aims to match the right patient with the right treatment using advanced technologies and data, differentiating itself by focusing on personalized treatment plans. Alto Neuroscience primarily targets patients with psychiatric conditions and healthcare providers seeking more effective, individualized treatment options.
3.6K
Volume
+250%
Growth
regular